EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and structure–activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agents

Baiyuan Yang, Paridhi Sukheja, Bo Qin, Gencheng Li, Grant A L Bare, Alessandro Cascioferro, Melissa S Love, H Michael Petrassi, K Barry Sharpless, Case W McNamara, Arnab K Chatterjee

Bioorganic & Medicinal Chemistry Letters · 2024

DOI: 10.1016/j.bmcl.2023.129596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2024. Verfasst von Baiyuan Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Calibr, a Division of Scripps Research, La Jolla, CA 92037, USA. Electronic address: byang@scripps.edu. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To identify new compounds that can effectively inhibit Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), we screened, synthesized, and evaluated a series of novel aryl fluorosulfate derivatives for their in vitro inhibitory activity against Mtb. Compound 21b exhibited an in vitro minimum inhibitory concentration (MIC) of 0.06 µM against Mtb, no cytotoxicity against both HEK293T and HepG2 mammalian cell lines, and had good in vivo mouse plasma exposure and lung concentration with a 20 mg/kg oral dose, which supports advanced development as a new chemical entity for TB treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosisAnimalsHumansMiceAntitubercular AgentsHEK293 CellsMammalsMicrobial Sensitivity TestsStructure-Activity RelationshipSulfuric Acid Esters

Stichwörter der Autor:innen

Anti-TB activityAryl fluorosulfateMycobacterium tuberculosisPharmacokineticStructure–activity relationship studiesSuFExSulfur (VI) fluoride exchange

Substanzen

Antitubercular AgentsSulfuric Acid Esters

Autor:innen und Institutionen

  • Calibr, a Division of Scripps Research, La Jolla, CA 92037, USA. Electronic address: byang@scripps.edu.
  • Calibr, a Division of Scripps Research, La Jolla, CA 92037, USA.
  • Department of Chemistry, Scripps Research, La Jolla, CA 92037, USA.

Förderung

  • Bill and Melinda Gates Foundation

Zitieren

APA

Yang, B., Sukheja, P., Qin, B., Li, G., Bare, G. A. L., Cascioferro, A., Love, M. S., Petrassi, H. M., Sharpless, K. B., McNamara, C. W., & Chatterjee, A. K. (2024). Synthesis and structure–activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agents. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2023.129596

Vancouver

Yang B, Sukheja P, Qin B, Li G, Bare GAL, Cascioferro A, et al. Synthesis and structure–activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agents. Bioorganic & Medicinal Chemistry Letters. 2024. doi:10.1016/j.bmcl.2023.129596

BibTeX
@article{Yang2024,
  author = {Yang, Baiyuan and Sukheja, Paridhi and Qin, Bo and Li, Gencheng and Bare, Grant A L and Cascioferro, Alessandro and Love, Melissa S and Petrassi, H Michael and Sharpless, K Barry and McNamara, Case W and Chatterjee, Arnab K},
  title = {Synthesis and structure–activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agents},
  journal = {Bioorganic & Medicinal Chemistry Letters},
  year = {2024},
  doi = {10.1016/j.bmcl.2023.129596}
}
Kostenlos starten →